Sutro Biopharma 2025 Financial Review

Sutro Biopharma 2025 Financial Review

Sutro Biopharma is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). For the year ended December…

BioAge Labs 2025 Financial Results Analysis

BioAge Labs Reports $80.

Talphera Q4 and Full Year 2025 Financial Update

Talphera is a specialty pharmaceutical company developing therapies for medically supervised settings. They are currently advancing their lead product candidate,…

Heidmar Maritime Holdings Corp. (HMR) Q4 Earnings: Misses on EPS, Revenue Recap

Substantial miss. Heidmar Maritime Holdings Corp. (NASDAQ:HMR) reported Q4 2025 GAAP earnings of -$0.07 per share, falling well short of…

Context Therapeutics 2025 Financial Review

Context Therapeutics is a clinical-stage biopharmaceutical company developing T cell engaging bispecific antibodies for solid tumors. The company reported a…

Lithium Argentina 2025 Financial Review

Lithium Argentina produces lithium carbonate primarily for the electric vehicle and battery markets. The company operates and holds a 44.8%…

Hour Loop, Inc. (HOUR) Reports FY2025 Results

Hour Loop, Inc.

Heidmar Maritime Holdings Corp. (HMR) Misses Q4 EPS Estimates

Heidmar Maritime Holdings Corp.

Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap

Disappointing quarter. Sanara MedTech Inc. (SMTI) reported Q4 2025 GAAP earnings of -$0.13 per share, falling short of the $0.11…

LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected

LENZ Therapeutics, Inc.